High complete remission rate and durable remissions achieved with rational use of autologous stem-cell transplantation, thalidomide maintenance, and non-myeloablative allogeneic transplantation in patients with multiple myeloma.


Oyan B. , Koc Y., Ozdemir E., Kars A., Turker A., Tekuzman G., et al.

Clinical transplantation, cilt.23, ss.839-47, 2009 (SCI İndekslerine Giren Dergi)